ACAD
Acadia Pharmaceuticals
$25.60
▼ -1.04%
−$0.27
NYSE · Healthcare · Biotechnology
· price updated 9h ago
Acadia Pharmaceuticals
ACAD · NYSE · Healthcare · Biotechnology · price updated 9h ago
$25.60
▼ -1.04% · −$0.27 today
AI research · $25.60
Track ACAD for continuous AI research
price position
Where ACAD sits now
52-week range
Low$19.69
High$28.35
Today $25.60
RSI (14)
44.9Neutral
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$851.5M
Total debt$39.0M
Net cash after debt$812.5M
Valuation
What the market charges
Forward P/E
Price against expected earnings
Needs attention · 86% above Sector avg
64.68x
Price / sales
Value assigned to each sales dollar
Reasonable · Between 3x and 8x sales
4.04x
Price / FCF
Price against free cash generation
Rich · Above 35x free cash flow
39.00x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
39.15x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Strong · At least 15% return on capital
17.8%
ROE
Profit generated from shareholder equity
Favorable · Exceptional vs sector peers
37.3%
Debt / equity
Balance-sheet leverage
Favorable · Exceptional vs sector peers
0.04x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
3.59x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How ACAD compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $4.43B | 11.8 | +9.9% | 59 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Acadia Pharmaceuticals (ACAD) stock
Acadia Pharmaceuticals tracked in the US core universe. ACAD was -1.0% in the latest available session at $25.60. Its reported market value was $4.43B with a trailing P/E of 11.8. Latest reported revenue was $1.09B, changing +9.9% year over year, with $375.65M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $25.60
- Day change
- -1.0%
- Market cap
- $4.43B
- P/E (TTM)
- 11.8
- Revenue growth
- +9.9%
- Industry
- Biotechnology